Encompass Health (MEX:EHC) Piotroski F-Score: 9 (As of Jul. 03, 2026) — 29% Above Median


MEX:EHC Encompass Health Corp MEX:EHC
88 GF Score
Price MXN1,280.08
GF Value MXN1,344.64
! 1 Warning Sign
View Full Analysis

What is Encompass Health Piotroski F-Score?

Encompass Health MEX:EHC 88 Piotroski F-Score is 9 as of Jul. 03, 2026, which is 29% above its 10-year median of 7.00. GuruFocus rates MEX:EHC with a GF Score™ of 88/100 and a GF Value™ of MXN1,344.64. The stock has 1 warning sign investors should review. Among 651 Healthcare Providers & Services companies, Encompass Health ranks better than 99.85% on this metric.

Good Sign:

Piotroski F-Score is 9, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Encompass Health has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Encompass Health's Piotroski F-Score or its related term are showing as below:

MEX:EHC' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 7   Max: 9
Current: 9

During the past 13 years, the highest Piotroski F-Score of Encompass Health was 9. The lowest was 4. And the median was 7.

Encompass Health  (MEX:EHC) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Encompass Health Piotroski F-Score Related Terms


Encompass Health Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Encompass Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Encompass Health Piotroski F-Score Chart

Encompass Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 5.00 7.00 7.00 9.00

Encompass Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.00 7.00 8.00 9.00 9.00

MEX:EHC vs ENSG, UHS, PACS: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, Encompass Health's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Encompass Health Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Encompass Health's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Encompass Health's Piotroski F-Score falls into.


MEX:EHC
88GF Score
Encompass Health Corp MEX:EHC
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 2675.629 + 2320.541 + 2630.633 + 3507.36 = MXN11,134 Mil.
Cash Flow from Operations was 5087.65 + 4967.609 + 6229.972 + 5646.038 = MXN21,931 Mil.
Revenue was 27447.325 + 27103.556 + 27811.604 + 28610.682 = MXN110,973 Mil.
Gross Profit was 26259.202 + 25918.52 + 26650.237 + 27451.179 = MXN106,279 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(135869.044 + 127769.302 + 125945.774 + 127655.011 + 131876.742) / 5 = MXN129823.1746 Mil.
Total Assets at the begining of this year (Mar25) was MXN135,869 Mil.
Long-Term Debt & Capital Lease Obligation was MXN49,042 Mil.
Total Current Assets was MXN18,557 Mil.
Total Current Liabilities was MXN15,811 Mil.
Net Income was 2090.324 + 2130.49 + 2521.454 + 3099.417 = MXN9,842 Mil.

Revenue was 23838.118 + 26601.595 + 29302.258 + 29774.864 = MXN109,517 Mil.
Gross Profit was 22782.88 + 25408.363 + 28002.948 + 28502.364 = MXN104,697 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(103417.903 + 117041.642 + 127167.834 + 136285.743 + 135869.044) / 5 = MXN123956.4332 Mil.
Total Assets at the begining of last year (Mar24) was MXN103,418 Mil.
Long-Term Debt & Capital Lease Obligation was MXN51,911 Mil.
Total Current Assets was MXN18,635 Mil.
Total Current Liabilities was MXN17,512 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Encompass Health's current Net Income (TTM) was 11,134. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Encompass Health's current Cash Flow from Operations (TTM) was 21,931. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=11134.163/135869.044
=0.08194775

ROA (Last Year)=Net Income/Total Assets (Mar24)
=9841.685/103417.903
=0.09516423

Encompass Health's return on assets of this year was 0.08194775. Encompass Health's return on assets of last year was 0.09516423. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Encompass Health's current Net Income (TTM) was 11,134. Encompass Health's current Cash Flow from Operations (TTM) was 21,931. ==> 21,931 > 11,134 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=49041.731/129823.1746
=0.37775791

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=51910.637/123956.4332
=0.41878131

Encompass Health's gearing of this year was 0.37775791. Encompass Health's gearing of last year was 0.41878131. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=18557.452/15811.071
=1.17369987

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=18635.374/17512.219
=1.0641355

Encompass Health's current ratio of this year was 1.17369987. Encompass Health's current ratio of last year was 1.0641355. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Encompass Health's number of shares in issue this year was 100.6. Encompass Health's number of shares in issue last year was 102.1. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=106279.138/110973.167
=0.95770123

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=104696.555/109516.835
=0.95598594

Encompass Health's gross margin of this year was 0.95770123. Encompass Health's gross margin of last year was 0.95598594. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=110973.167/135869.044
=0.81676564

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=109516.835/103417.903
=1.05897366

Encompass Health's asset turnover of this year was 0.81676564. Encompass Health's asset turnover of last year was 1.05897366. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+1+1+0
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Encompass Health has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 9 mean?
Encompass Health (MEX:EHC) has a Piotroski F-Score of 9 as of Jul. 03, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Encompass Health and its competitors. This is 29% above median its historical median of 7.00. Over the past decade, Encompass Health's Piotroski F-Score has ranged from 4.00 to 9.00. According to the industry distribution chart, Encompass Health ranks #1 out of 651 companies in the Healthcare Providers & Services industry, placing it in the top 0.2%.
Is Encompass Health's Piotroski F-Score too high?
Encompass Health's current Piotroski F-Score of 9 is 29% above median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 9.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Encompass Health's value of 9 is 80% above this industry median. Based on the distribution chart, Encompass Health ranks #1 out of 651 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Encompass Health has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Encompass Health's Piotroski F-Score compare to ENSG and UHS?
According to the Healthcare Providers & Services industry distribution chart, Encompass Health ranks #1 out of 651 companies for Piotroski F-Score. This places Encompass Health in the top 0% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Encompass Health's value of 9 is 80% above this benchmark. Historically, Encompass Health's own Piotroski F-Score has ranged from 4.00 to 9.00 over the past decade. While the company's 10-year median is 7.00 vs. the industry median of 5.00, Encompass Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 651 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Encompass Health's current Piotroski F-Score of 9 is 80% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Encompass Health and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Encompass Health's current Piotroski F-Score is 9, which is 29% above median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encompass Health stock overvalued right now?
Encompass Health (MEX:EHC) has a current Piotroski F-Score of 9. The stock's GF Value™ is MXN1,344.64, compared to a current price of MXN1,280.08 — trading 4.8% below its estimated fair value. The current Piotroski F-Score is 9, which is 29% above median its 10-year median of 7.00 and 80% above the Healthcare Providers & Services industry median of 5.00. Encompass Health's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Encompass Health (MEX:EHC), the current Piotroski F-Score is 9 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Encompass Health (MEX:EHC) Overvalued in 2026?

Based on GuruFocus' analysis, Encompass Health stock appears to be undervalued. The current stock price of MXN1,280.08 is trading 4.8% below its estimated GF Value™ of MXN1,344.64.

Key valuation signals for MEX:EHC:

  • Piotroski F-Score: 9 (29% above median its 10-year median of 7.00)
  • GF Value™: MXN1,344.64 vs. price of MXN1,280.08 (4.8% below fair value)
  • GF Score™: 88/100 with 1 warning sign
  • Industry Position: 80% above the Healthcare Providers & Services median (#1 of 651)

No single metric tells the full story. See the MEX:EHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Encompass Health Business Description

Other Exchanges EHC:USA
Address 9001 Liberty Parkway, Birmingham, AL, USA, 35242
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
88GF Score

Get the complete analysis for MEX:EHC

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,280.08
Price
MXN1,344.64
GF Value